Dependence on zolpidem: Is pharmacokinetics important? [2]

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 1, 2008, Pages 127-

  Cubała, Wiesław Jerzy ^a   Wichowicz, Hubert Michał ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYL GLUTARYL COA REDUCTASE INHIBITOR; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIEPILEPSIRINE; ANTIGESTAGEN; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OXIDOREDUCTASE; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZOLPIDEM;

BLOOD LEVEL; CONTRACEPTION; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; HUMAN; KIDNEY FAILURE; LETTER; LIVER DYSFUNCTION; LIVER METABOLISM; PLASMA PROTEIN BINDING; SEX DIFFERENCE; WITHDRAWAL SEIZURE; WITHDRAWAL SYNDROME;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPNOTICS AND SEDATIVES; METABOLIC CLEARANCE RATE; METABOLIC DETOXICATION, DRUG; PYRIDINES; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 39149109246     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01784.x     Document Type: Letter

References (7)

1. Huang MC, Lin HY, Chen CH. Dependence on zolpidem. Psychiatry Clin. Neurosci. 2007 61 : 207 208.
2. Cubala WJ, Landowski J. Seizure following sudden zolpidem withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 539 540.
3. Tripodianakis J, Potagas C, Papageorgiou P, Lazaridou M, Matikas N. Zolpidem-related epileptic seizures: A case report. Eur. Psychiatry 2003 18 : 140 141.
4. Greenblatt DJ, Harmatz JS, von Moltke LL et al. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: Evaluation of sex-dependent differences. J. Pharmacol. Exp. Ther. 2000 293 : 435 443.
5. Von Moltke LL, Greenblatt DJ, Granda BW et al. Zolpidem metabolism in vitro: Responsible cytochromes, chemical inhibitors, and in vivo correlations. Br. J. Clin. Pharmacol. 1999 48 : 89 97.
6. Olubodun JO, Ochs HR, Trüten V et al. Zolpidem pharmacokinetic properties in young females: Influence of smoking and oral contraceptive use. J. Clin. Pharmacol. 2002 42 : 1142 1146.
7. Pacifici GM, Viani A, Rizzo G et al. Plasma protein binding of zolpidem in liver and renal insufficiency. Int. J. Pharmacol. Ther. Toxicol. 1988 26 : 439 443.